Search research articles
Contact Us
Filters
Showing results (11-20 of 166) with videos related to
Page
of 17
Sort By:
Drug Design, Development and Therapy
|
August 28, 2018
Current research for a vaccine against Lassa hemorrhagic fever virus
Bryce M Warner, David Safronetz, Derek R Stein
Advances in Experimental Medicine and Biology
|
October 11, 2016
Syrian Hamsters as a Small Animal Model for Emerging Infectious Diseases: Advances in Immunologic Methods
Bryce M Warner, David Safronetz, Gary P Kobinger
Plos Computational Biology
|
January 7, 2021
Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin
Guillaume Lingas, Kyle Rosenke, David Safronetz, et al.
Virology Journal
|
December 20, 2024
Current perspectives on vaccines and therapeutics for Lassa Fever
Bryce M Warner, David Safronetz, Derek R Stein
Antiviral Research
|
June 19, 2012
The Syrian hamster model of hantavirus pulmonary syndrome
David Safronetz, Hideki Ebihara, Heinz Feldmann, et al.
Emerging Infectious Diseases
|
February 21, 2025
Sin Nombre Virus as Unlikely Reverse Zoonotic Threat
Jérémie Prévost, Nikesh Tailor, Anders Leung, et al.
Journal of Immunological Methods
|
February 22, 2011
Validation of assays to monitor immune responses in the Syrian golden hamster (Mesocricetus auratus)
Marko Zivcec, David Safronetz, Elaine Haddock, et al.
Science (New York, N.Y.)
|
August 13, 2016
Response to Comment on "Mutation rate and genotype variation of Ebola virus from Mali case sequences"
Thomas Hoenen, Allison Groseth, David Safronetz, et al.
Plos One
|
August 20, 2011
In vitro and in vivo activity of ribavirin against Andes virus infection
David Safronetz, Elaine Haddock, Friederike Feldmann, et al.
Plos Neglected Tropical Diseases
|
July 17, 2018
Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge
Marko Zivcec, David Safronetz, Dana P Scott, et al.
Page
of 17
Search research articles
Search
Showing results (11-20 of 166) with videos related to
Sort By:
Page
of 17
Drug Design, Development and Therapy
|
August 28, 2018
Current research for a vaccine against Lassa hemorrhagic fever virus
Bryce M Warner, David Safronetz, Derek R Stein
Advances in Experimental Medicine and Biology
|
October 11, 2016
Syrian Hamsters as a Small Animal Model for Emerging Infectious Diseases: Advances in Immunologic Methods
Bryce M Warner, David Safronetz, Gary P Kobinger
Plos Computational Biology
|
January 7, 2021
Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin
Guillaume Lingas, Kyle Rosenke, David Safronetz, et al.
Virology Journal
|
December 20, 2024
Current perspectives on vaccines and therapeutics for Lassa Fever
Bryce M Warner, David Safronetz, Derek R Stein
Antiviral Research
|
June 19, 2012
The Syrian hamster model of hantavirus pulmonary syndrome
David Safronetz, Hideki Ebihara, Heinz Feldmann, et al.
Emerging Infectious Diseases
|
February 21, 2025
Sin Nombre Virus as Unlikely Reverse Zoonotic Threat
Jérémie Prévost, Nikesh Tailor, Anders Leung, et al.
Journal of Immunological Methods
|
February 22, 2011
Validation of assays to monitor immune responses in the Syrian golden hamster (Mesocricetus auratus)
Marko Zivcec, David Safronetz, Elaine Haddock, et al.
Science (New York, N.Y.)
|
August 13, 2016
Response to Comment on "Mutation rate and genotype variation of Ebola virus from Mali case sequences"
Thomas Hoenen, Allison Groseth, David Safronetz, et al.
Plos One
|
August 20, 2011
In vitro and in vivo activity of ribavirin against Andes virus infection
David Safronetz, Elaine Haddock, Friederike Feldmann, et al.
Plos Neglected Tropical Diseases
|
July 17, 2018
Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge
Marko Zivcec, David Safronetz, Dana P Scott, et al.
Page
of 17